The US Food and Drug Administration (FDA) could soon implement measures to speed up processes that help companies obtain approvals for new vaping products and nicotine pouches, according to a Reuters report that cited in a Wall Street Journal report. The agency is expected to revisit rules introduced in 2021 to simplify some scientific requirements and shorten timelines of review of these products, allowing them to move through the approval process swiftly and smoothly. It is important to note that Reuters could not verify the report independently. The FDA, too, had not responded to a request for a comment. The development is slightly alarming as even though these products are often positioned as alternatives to traditional cigarettes, they are not essentially safer. Are Vapes Safer Than Conventional Cigarettes? Most e-cigarettes contain nicotine, which is a highly addictive substance. The aerosol produced by a vape can also contain harmful substances, including cancer-causing chemicals, heavy metals like nickel, tin and lead, and other tiny particles that can travel into the lungs, leaving lasting damage. It is also important to understand that the long-term effects of vaping are still being studied. For adults who already smoke cigarettes, the FDA says switching completely to e-cigarettes may reduce damage that stem from harmful chemicals found in cigarette smoke. But continuing to smoke while vaping, known as dual use, does not provide any benefit. Hence, FDA authorisation is not a declaration or proof that a product is risk-free.Also read: Never Smoked, Still Got Lung Cancer? Rare Gene Mutation Linked To Over 60x RiskNicotine Pouches Nicotine pouches do not produce smoke or an inhaled aerosol. Instead, the pouch is placed in the mouth, where nicotine is absorbed through the gums and lining of the mouth. Again, nicotine pouches may pose lesser risk than tobacco cigarettes, but it still contains nicotine. The FDA says nicotine pouches can generally be a lower-risk alternative for adults who smoke cigarettes if they switch completely, because they can reduce exposure to many harmful chemicals found in cigarettes. But they are not risk-free, and the FDA has not approved nicotine pouches as medicines to help quit smoking. The agency has already authorised some nicotine pouch products after reviewing their risks and benefits. In August 2026, it authorised four additional products through its nicotine pouch pilot programme. Nicotine is highly addictive and can affect the brain, especially in the younger population. Nicotine pouches can also contain relatively high levels of nicotine, and scientists are still studying their short as well as long-term health effects.Also read: It’s Not Just Tobacco: The Hidden Oral Cancer Risks We Rarely Talk AboutWhy FDA Is Pushing For Does Faster Approval For These Products? The FDA's move is essentially about how quickly products can be reviewed and approved, not about removing the requirement that products meet a specific public-health standard. The FDA says authorised products must prove that their benefits for the public as a whole is greater than the risks they pose. At the same time, it continues to state that there are no safe tobacco products, and people who do not use tobacco should not start using vapes or nicotine pouches.